SV Health Investors hits $265m final close for first dedicated biotech fundraise
SV Health Investors has hit a $265m final close for its first dedicated biotech fundraise.
SV Health Investors has hit a $265m final close for its first dedicated biotech fundraise.
Blackstone has raised $4.6bn for the biggest-ever private equity fund dedicated to life sciences investments, hitting its hard cap for the vehicle.
European life science and healthcare investor LSP has led a €32m Series B financing round for VarmX, a biotech company focused on developing approaches for the reversal of anticoagulation.
Spanish early stage investment house Ysios Capital has hit €155m for its third life science fund - and could go as high as €200m for the vehicle.
Protera, an AI-driven startup designing and developing new proteins, has closed a $5.6m Series A financing led by European life sciences venture capital major Sofinnova Partners.
Advanced therapies-focused venture capital firm 4BIO Capital has picked up a strategic investment in its newest fund from specialist pharma and biotech business Kyowa Kirin.
